Login to Your Account



U.S. Reform, Global Markets . . .

Ziopharm's Bet: Cancer Pills Will Beat I.V.; Off-On Method Intrigues

By Randy Osborne


Monday, November 16, 2009
"Ruthlessly efficient" is how Jonathan Lewis, CEO and chief medical officer of Ziopharm Oncology Inc., last week described his firm's approach to research and financial management.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription